IGC News and Press, India Globalization Capital Inc. From 07/20/20

India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) recently received a Notice of Allowance dated July 8, 2020 from the United States Patent and Trademark Office (“USPTO”) for the Company’s cannabinoid formulation for the treatment of seiz...

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the Fiscal Year Ended March 31, 2020. During Fiscal 2020, total revenue was approximately $4.1 million compared to approximately $5.1 million for Fiscal 2019. In both years, revenue was primarily de...

India Globalization Capital, Inc. (the “Company”) (NYSE: IGC) announces today the proposed settlement of three derivative lawsuits pending since 2018 and 2019 and provides notice to shareholders of the settlement. As previously disclosed on February 10, 2020, the Company ent...

India Globalization Capital, Inc. (the “Company”) (NYSE: IGC) recently received notification that on March 24, 2020, the United States Patent and Trademark Office (“USPTO”) issued a method and composition patent (#10,596,159 B2) for the Company’s cannabinoid...

India Globalization Capital (NYSEMKT: IGC ): Q3 GAAP EPS of -$0.04. More news on: India Globalization Capital, Inc., Earnings news and commentary, , Read more ...

India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended December 31, 2019, which is the third quarter of its 2020 fiscal year. Revenue amounted to approximately $573 thousand and $1,285 thousand, for the three months ended December 31...

India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended September 30, 2019, which is the second quarter of its 2020 fiscal year. Revenue for the September 2019 quarter rose 125% to approximately $1.8 million compared to approximately ...

Targets Expansion of Products to Latin America India Globalization Capital, Inc. (NYSE: IGC) announced today that it has opened a marketing and research office in Colombia, South America. Hamsa Biochem SAS, a new beneficially owned subsidiary of IGC, will focus on marketing and resea...

After each Alzheimer’s drug failure, the inevitable question is always asked what are we doing wrong. Anavex ( AVXL ), Glovia, and India Globalization Capital ( IGC ) are three companies that may have the correct answer. Each company’s drug candidate acts as an antioxidant and ...

AIM ImmunoTech (NYSEMKT: AIM ) +92%  on DoD grant for cancer study. More news on: AIM ImmunoTech Inc., Eros International Plc, Westwater Resources, Inc., Stocks on the move, Read more ...